Your trusted guide to clinical trials
Find clinical trials relevant to you, near you. Powered by AI.
Become a Research Volunteer.
Get notified about future clinical trial opportunities.
Browse Trials by Condition
- Barrett's Esophagus 2,783
- Neoplasms 1,209
- Lymphocytic Leukemia, Acute 1,015
- Metastatic Cancer 753
- Neoplasm Metastasis 751
- Menstruation 643
- Surgery 549
- Lung Disease 521
- Allergy 501
- Uterine Fibroids 429
- Neurologic Disorders 415
- Pain 381
- Viral Infections 348
- Chemotherapy 331
- Wounds 305
- Vision Loss 271
- Vascular Diseases 254
- Asthma 251
- Metabolic Disorders 216
- Heart Disease 212
- Diabetes Mellitus, Type 2 210
TrialX — your clinical trial finder
A new, easy way to participate in clinical studies.
New & updated studies
Browse all studies
Comparison of Hand Eye Coordination and Sports Vision Performance in Dual-Focus Multifocal Contact Lenses and Habitual Contact Lenses
The purpose of the study is to compare the hand-eye coordination and sports vision performance in participants while they are wearing their habitual contact lenses versus while wearing the dual-focus multifocal contact lenses.
Operating-Room Distractions, Surgeon Workload, Anxiety, Teamwork and Intraoperative Adverse Events (ORCHESTRA)
During surgery, telephone calls, conversations, equipment problems and other events may distract the operating team. Some events interrupt the progress of the operation. The surgeon's workload and anxiety, together with how well the team works together, may also be related to events that occur during surgery. ORCHESTRA is an observational …
A Study to Investigate the Efficacy and Safety of Rilzabrutinib in Adult Participants With Graves' Disease
This is a parallel group, Phase 2, 2-arm study to measure the treatment effect and safety of rilzabrutinib dose 1 or rilzabrutinib dose 2 in participants with Graves' disease, with and without Graves' orbitopathy, aged 18 years or older.Study details include:Screening period (up to 4 weeks).Treatment period (up to 16 …
A 52-week Study of Remibrutinib in IgE-mediated Food Allergy
The purpose of this Phase III study is to evaluate the clinical efficacy and safety of remibrutinib in participants with peanut, or cow's milk ("milk", cooked and uncooked) or hen's egg ("egg", cooked and uncooked) immunoglobulin E (IgE)- mediated allergy in comparison to placebo.
Your clinical trial journey
Find a study
Search or browse for a clinical trial near you.
Check Eligibility
Learn more about the study and check to see if you are eligible to take part in it.
Participate
If you prequalify, connect with the study team and let your trial journey begin!
Accelerating clinical research powered by AI
Building patient connection for a better future
Join us in our mission to help accelerate clinical research.
We are on a mission to make 1 billion actions made towards clinical research. ‘Actions’ are anything from searching for trials, sharing a trial, getting in touch with a study team — or something as simple as becoming a volunteer.